NCT04025658View on ClinicalTrials.gov

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 6, 2019

Primary Completion Date

September 7, 2021

Study Completion Date

September 8, 2021

Conditions
Postpartum HemorrhageTwin
Interventions
DRUG

Oxytocin

Oxytocin administered intravenously, over 1 minute following delivery of the fetal head

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT04025658 - Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy | Biotech Hunter | Biotech Hunter